Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension

Journal of Hypertension

Volumn 24, Issue 7, 2006, Pages 1281-1286

  Viazzi, Francesca ^a   Leoncini, Giovanna ^a   Sacchi, Giorgio ^b   Parodi, Denise ^a   Ratto, Elena ^a   Falqui, Valeria ^a   Parodi, Angelica ^a   Vaccaro, Valentina ^a   Tomolillo, Cinzia ^a   Deferrari, Giacomo ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Artificial neural network; Cardiovascular risk stratification; Creatinine clearance; Primary hypertension; Target organ damage

Indexed keywords

CHOLESTEROL; CREATININE; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMINURIA; ARTICLE; ARTIFICIAL NEURAL NETWORK; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE DURATION; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL SOCIETY; MICROALBUMINURIA; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 33745447433     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000234107.08368.e5     Document Type: Article

References (34)

1. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension 2003. Guidelines Committee. J Hypertens 2003; 21:1011-1053.
2. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A, on behalf of the APROS Investigators. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20:1307-1314.
3. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, et al. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. J Hypertens 2002; 20:1315-1321.
4. Viazzi F, Parodi D, Leoncini G, Vettoretti S, Ratto E, Vaccaro V, et al. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. J Hypertens 2004; 22:907-913.
5. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289:2560-2572.
6. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
7. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JI, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41:47-55.
8. Manjunath G, Tighiouart H, Coresh J, MacLeod B, Salem DN, Griffith JI, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003; 63:1121-1129.
9. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
10. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
11. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346:1135-1138.
12. Cross SS, Harrison FH, Kennedy RL. Introduction to neural networks. Lancet 1995; 346:1075-1079.
13. Reggia JA. Neural computation in medicine. Artif Intell Med 1993; 5:143-157.
14. Orunesu E, Bagnasco M, Salmaso C, Altrinetti V, Bernasconi D, Delmonte P, et al. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal. Eur J Clin Invest 2004; 34:210-217.
15. Heston TF, Norman DJ, Barry JM, Bennett WM, Wilson RA. Cardiac risk stratification in renal transplantation using a form of artificial intelligence. Am J Cardiol 1997; 79:415-417.
16. Goldfarb-Rumyantzev AS, Pappas L. Prediction of renal insufficiency in Pima Indians with nephropathy of type 2 diabetes mellitus. Am J Kidney Dis 2002; 40:252-264.
17. Geddes CC, Fox JG, Allison ME, Boullton-Jones SM, Simpson K. An artificial neural network can select patients at high risk of developing progressive IgA nephropathy more accurately than experienced nephrologists. Nephrol Dial Transplant 1998; 13:67-71.
18. Guh JY, Yang CY, Yang JM, Chan LM, Lai YH. Prediction of equilibrated postdialysis BUN by an artificial neural network in high-efficiency hemodialysis. Am J Kidney Dis 1998; 31:638-646.
19. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension 1997; 30:1135-1143.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
21. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb reads. Am Heart J 1949; 37:161-186.
22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
23. Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al. Improved sex-specific detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985; 6:572-580.
24. Tourassi GD, Floyd CE. The effect of data sampling on the performance evaluation of artificial neural networks in medical diagnosis. Med Decis Making 1997; 17:186-192.
25. Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RS, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int 2002; 62:1402-1407.
26. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12:218-225.
27. de Leeuw PW, Ruilope LM, Palmer CR, Brown MJ, Castaigne A, Mancia G, et al. Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch Intern Med 2004; 164:2459-2464.
28. Mlekusch W, Exner M, Sabeti S, Amighi J, Schlager O, Wagner O, et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. Atherosclerosis 2004; 175:361-367.
29. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C, et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003; 91:1051-1054.
30. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. GRACE Investigators. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart 2003; 89:1003-1008.
31. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295.
32. Ritz E. Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart 2003; 89:963-964.
33. Leoncini G, Viazzi F, Parodi D, Vettoretti S, Ratto E, Ravera M, et al. Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. Hypertension 2003; 42:14-18.
34. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41:1-12.